Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $80,727 | 1 | 98.4% |
| Unspecified | $954.32 | 9 | 1.2% |
| Food and Beverage | $333.84 | 3 | 0.4% |
| Education | $9.56 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $81,816 | 12 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2019) |
| Acorda Therapeutics, Inc | $83.85 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $259.55 | 3 | Biogen, Inc. ($134.56) |
| 2018 | $81,765 | 11 | Biogen, Inc. ($81,681) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 08/19/2019 | Biogen, Inc. | TYSABRI (Biological) | Education | In-kind items and services | $9.56 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2019 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 11/09/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $63.65 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/09/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $47.04 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/09/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $35.26 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $324.20 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $166.88 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $144.19 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $92.89 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $47.04 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 11/08/2018 | Biogen, Inc. | — | — | Cash or cash equivalent | $33.17 | Research |
| Study: MS PATHS Normative Sub-Study | ||||||
| 02/19/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Food and Beverage | Cash or cash equivalent | $83.85 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 02/01/2018 | Biogen, Inc. | — | Grant | Cash or cash equivalent | $80,726.94 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MS PATHS Normative Sub-Study | Biogen, Inc. | $954.32 | 9 |
About Gabrielle Macaron
Gabrielle Macaron is a Neurology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1720592652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gabrielle Macaron has received a total of $82,025 in payments from pharmaceutical and medical device companies, with $259.55 received in 2019. These payments were reported across 14 transactions from 3 companies. The most common payment nature is "Grant" ($80,727).
Practice Information
- Specialty Neurology
- Location Cleveland, OH
- Active Since 11/30/2017
- Last Updated 11/30/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720592652
Products in Payments
- SOLIRIS (Drug) $124.99
- AMPYRA (Drug) $83.85
- TYSABRI (Biological) $9.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cleveland
Imad Najm, Md, MD
Neurology — Payments: $428,375
Dr. Robert Bermel, M.d, M.D
Neurology — Payments: $427,113
Robert Fox, Md, MD
Neurology — Payments: $403,845
Benjamin Walter, Md, MD
Neurology — Payments: $384,235
Dr. Mary Willis, M.d, M.D
Neurology — Payments: $361,341
Mary Rensel, Md, MD
Neurology — Payments: $288,222